Synairgen plc (SYGGF)

OTCMKTS · Delayed Price · Currency is USD

0.0001

0.00 (0.00%)

At close: Mar 9, 2026

Synairgen Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	3.53	2.72	3.76	5.36	5.01
Research & Development	9.33	5.61	6.53	14.94	52.86
Operating Expenses	12.86	8.32	10.29	20.3	57.87
Operating Income	-12.86	-8.32	-10.29	-20.3	-57.87
Interest Expense	-	-	-	-	-0
Interest & Investment Income	0.73	0.4	0.64	0.21	0.01
Pretax Income	-12.13	-7.93	-9.66	-20.09	-57.86
Income Tax Expense	-	-1.12	-1.25	-2.45	-9.19
Net Income	-12.13	-6.81	-8.41	-17.65	-48.66
Net Income to Common	-12.13	-6.81	-8.41	-17.65	-48.66
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	1,068	202	201	201	200
Shares Outstanding (Diluted)	1,068	202	201	201	200
Shares Change	429.84%	0.11%	0.01%	0.46%	36.24%
EPS (Basic)	-0.01	-0.03	-0.04	-0.09	-0.24
EPS (Diluted)	-0.01	-0.03	-0.04	-0.09	-0.24
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-10.62	-7.9	-8.23	-14.29	-41.03
Free Cash Flow Per Share	-0.01	-0.04	-0.04	-0.07	-0.20
EBITDA	-12.52	-8.29	-10.21	-20.2	-57.77
D&A For EBITDA	0.34	0.03	0.08	0.1	0.1
EBIT	-12.86	-8.32	-10.29	-20.3	-57.87